FDA approves Pulmonx's valve to treat lung disease
The U.S. Food and Drug Administration approved Pulmonx Inc’s valve to treat a severe form of obstructive lung disease, most often characterized by shortness of breath. Treatment for severe emphysema, which damages air sacs in the lungs and limits patients’ breathing ability, is currently limited to capsules and inhalers.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063